全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Liposarcoma of the Spermatic Cord Masquerading as an Inguinal Hernia

DOI: 10.1155/2014/735380

Full-Text   Cite this paper   Add to My Lib

Abstract:

This is a case of a 70-year-old male who presented with a mass in his right testicle. He was treated with antibiotics for epididymitis while undergoing serial ultrasounds for one year due to testicular swelling and pain. His fourth ultrasound revealed a mild hydrocele with a large paratesticular mass of undescribed size, superior to the right testicle, thought to be an inguinal hernia. Preoperative CT scan demonstrated a large fat-containing inguinal hernia extending into the scrotal sac. An inguinal hernia repair was complicated by fatty tissue surrounding the testicle requiring a right orchiectomy. Pathology review of the tissue demonstrated well-differentiated liposarcoma with a small focus of dedifferentiation grade 2 tumor. Tumor was identified at the inked margins indicating an incomplete resection. It was decided that no further surgical intervention was needed and the patient would undergo surveillance for local tumor recurrence. Six-month follow-up MRI scan was negative for any recurrence of disease. A liposarcoma presenting as a paratesticular mass with spermatic cord involvement is rare, and imaging studies may fail to distinguish a liposarcoma from normal adipose tissue. 1. Introduction Liposarcoma is a malignant soft tissue sarcoma typically occurring in the thigh or retroperitoneum in an adult. However, a liposarcoma presenting as a paratesticular mass with spermatic cord involvement is rare. The first reported case was in 1845 and only 100 cases are found in the literature [1]. The diagnosis is hard to obtain due to the tumor being low grade and difficult to distinguish from an inguinal hernia due to adipose tissue composition when viewed on MRI, CT, or ultrasound [2]. 2. Case A 70-year-old male presented to his internal medicine primary care physician with a mass and swelling of his right testicle. Initial evaluation demonstrated a negative polymerase chain reaction (PCR) test for gonorrhea and chlamydia. Beta-human chorionic gonadotropin (HCG), lactate dehydrogenase (LDH), and -fetoprotein (AFP) tests were within normal limits. He was treated empirically with antibiotics for epididymitis before the laboratory results returned. A screening testicular ultrasound demonstrated an extratesticular mass thought to be an inguinal hernia because of its reducibility on exam. Since it was reducible and he was not in pain, no further workup or surgical intervention was performed. On continued follow-up appointments with his primary care physician, he noted increasing swelling and pain at the site of the mass, prompting a repeat ultrasound. The

References

[1]  Chintamani, M. Tandon, R. Khandelwal et al., “Liposarcoma of the spermatic cord: a diagnostic dilemma,” JRSM Short Reports, vol. 1, no. 6, p. 49, 2010.
[2]  J. J. Peterson, M. J. Kransdorf, L. W. Bancroft, and M. I. O'Connor, “Malignant fatty tumors: classification, clinical course, imaging appearance and treatment,” Skeletal Radiology, vol. 32, no. 9, pp. 493–503, 2003.
[3]  S. M. Wampler and M. Llanes, “Common scrotal and testicular problems,” Primary Care, vol. 37, no. 3, pp. 613–626, 2010.
[4]  NCCN Guidelines Version 1.2012 Testicular Cancer.
[5]  K. M. Dalal, C. R. Antonescu, and S. Singer, “Diagnosis and management of lipomatous tumors,” Journal of Surgical Oncology, vol. 97, no. 4, pp. 298–313, 2008.
[6]  M. A. Clark, C. Fisher, I. Judson, and J. Meirion Thomas, “Soft-tissue sarcomas in adults,” New England Journal of Medicine, vol. 353, no. 7, pp. 701–711, 2005.
[7]  R. Grimer, I. Judson, D. Peake, and B. Seddon, “Guidelines for the management of soft tissue sarcomas,” Sarcoma, vol. 2010, Article ID 506182, 15 pages, 2010.
[8]  ESMO/European Sarcoma Network Working Group, “Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up,” Annals of Oncology, vol. 23, supplement 7, pp. vii92–vii99, 2012.
[9]  NCCN Guidelines Version 1. 2013 Soft Tissue Sarcoma.
[10]  P. J. Woodward, C. M. Schwab, and I. A. Sesterhenn, “From the archives of the AFIP: extratesticular scrotal masses: radiologic-pathologic correlation,” Radiographics, vol. 23, no. 1, pp. 215–240, 2003.
[11]  L. Abete, A. Simonato, C. Toncini, G. Carmignani, and L. E. Derchi, “Myxoid liposarcoma of the spermatic cord: US and MR imaging findings,” Journal of Clinical Ultrasound, 2013.
[12]  K. Yoshida, E. Nakamura, T. Kawahara et al., “A case of myxoid liposarcoma in the right inguinal region: a case report,” Acta Urologica Japonica, vol. 52, no. 9, pp. 727–731, 2006.
[13]  K. M. Alektiar, J. Velasco, M. J. Zelefsky, J. M. Woodruff, J. J. Lewis, and M. F. Brennan, “Adjuvant radiotherapy for margin-positive high-grade soft tissue sarcoma of the extremity,” International Journal of Radiation Oncology Biology Physics, vol. 48, no. 4, pp. 1051–1058, 2000.
[14]  S. Singer, C. R. Antonescu, E. Riedel, M. F. Brennan, and R. E. Pollock, “Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma,” Annals of Surgery, vol. 238, no. 3, pp. 358–371, 2003.
[15]  N. Pervaiz, N. Colterjohn, F. Farrokhyar, R. Tozer, A. Figueredo, and M. Ghert, “A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma,” Cancer, vol. 113, no. 3, pp. 573–581, 2008.
[16]  A. Italiano, F. Delva, S. Mathoulin-Pelissier et al., “Effect of adjuvant chemotherapy on survival in FNCLCC grade 3 soft tissue sarcomas: a multivariate analysis of the French Sarcoma Group Database,” Annals of Oncology, vol. 21, no. 12, pp. 2436–2441, 2010.
[17]  M. J. Khandekar, C. P. Raut, J. L. Hornick, Q. Wang, B. M. Alexander, and E. H. Baldini, “Paratesticular liposarcoma: unusual patterns of recurrence and importance of margins,” Annals of Surgical Oncology, vol. 20, no. 7, pp. 2148–2155, 2013.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133